Advertisement

Diagnose und Therapie des Parkinson-Tremors

  • G. Deuschl

Zusammenfassung

Der Ruhetremor ist eines der vier Kardinalsymptome der Parkinsonschen Krankheit (neben Akinese, Rigor, und einer Störung der Standreflexe). Allerdings kommen bei genauer Betrachtung unterschiedliche Tremorformen bei der Parkinsonschen Krankheit (PD) vor, die unterschiedlich therapiert werden und daher diagnostisch sorgfältig unterschieden werden müssen. Außerdem sind einige andere Tremorformen auszuschließen, die häufig mit dem ParkinsonTremor verwechselt werden. Die vorliegende übersicht faßt Differentialdiagnose und Therapie zusammen.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Baas H, Stecker K, Fischer PA (1993) Value and appropriate use of rating scales and apparative measurements in quantification of disability in Parkinson’s disease. J Neural Transm [PD Sect] 5: 45–61CrossRefGoogle Scholar
  2. Bain P (1993) A combined clinical and neuro-physiological approach to the study of patients with tremor. J Neurol Neurosurg Psychiatry 56: 839–844PubMedCrossRefGoogle Scholar
  3. Bain PG, Mally J, Gresty M, Findley LJ (1993) Assessing the impact of essential tremor on upper limb function. J Neurol 241: 54–61PubMedCrossRefGoogle Scholar
  4. Benabid AL, Pollak P, Hommel M, Gaio JM, De Rongement J, Perret J (1989) Treatment of Parkinson tremor by chronic stimulation of the ventral intermediate nucleus of the thalamus [French]. Rev Neurol 145: 320–323PubMedGoogle Scholar
  5. Benabid AL, Pollak P, Gervason C, Hoffmann D, Gao DM, Hommel M, Perret JE, de Rongement J (1991) Long-term suppression of tremor by chronic stimulation of the ventral intermediate thalamic nucleus. Lancet 337: 403–406PubMedCrossRefGoogle Scholar
  6. Blond S, Siegfried J (1991) Thalamic stimulation for the treatment of tremor and other movement disorders. Acta Neurochir [Suppl] 52: 109–111CrossRefGoogle Scholar
  7. Brooks DJ, Playford ED, Ibanez V, Sawle GV, Thompson PD, Findley LJ, Marsden CD (1992) Isolated tremor and disruption of the nigro-striatal dopaminergic system: an 18F-dopa PET study. Neurology 42: 1554–1560PubMedCrossRefGoogle Scholar
  8. Cantello R, Riccio A, Gilli M, Delsedime M, Scarzella L, Aguggia M, Bergamasco B (1986) Bornaprine vs placebo in Parkinson disease: double-blind controlled cross-over trial in 30 patients. Ital J Neurol Sci 7: 139–143PubMedCrossRefGoogle Scholar
  9. Caparros LD, Ruchoux MM, Blond S, Petit H, Percheron G (1994) Long-term thalamic stimulation in Parkinson’s disease: postmortem ana-tomoclinical study. Neurology 44: 1856–1860CrossRefGoogle Scholar
  10. Chen R, Ashby P, Lang AE (1992) Stimulus-sensitive myoclonus in akinetic-rigid syndromes. Brain 115: 1875–1888PubMedCrossRefGoogle Scholar
  11. Corbin KB (1949) Trihexyphenidyl: evaluation of the new agent in the treatment of parkinsonism. JAMA 141: 377–382CrossRefGoogle Scholar
  12. Deuschl G (1995) Tremor — aktueller Stand in Forschung und Klinik. In: Elger CE, Dengler R (Hrsg) Jahrbuch der Neurologie 1995. Biermann Verlag, ZülpichGoogle Scholar
  13. Deuschl G, Lücking CH (1989) Tremor and electrically elicited long-latency reflexes in early stages of Parkinson’s disease. In: Riederer P et al. (eds) Early diagnosis and preventive therapy of Pakinson’s disease. Springer, Wien New York, pp 103–110 (Key Topics in Brain Research)CrossRefGoogle Scholar
  14. Deuschl G, Koester B (1996) Diagnose und Behandlung des Tremors. In: Conrad B, Cebal-Los-Baumann AO (Hrsg) Bewegungsstörungen in der Neurologic Thieme, Stuttgart New York, S 222–253Google Scholar
  15. Deuschl G, Bain P, Brin M (1998) Tremor: consensus-statement of the movement disorder Society. Mov Disord 13 [Suppl 3]: 2–23PubMedGoogle Scholar
  16. Feifel E, Brenner M, Teiwes R, Lücking CH, Deuschl G (1994) Corticobasale Degeneration. Die Bedeutung klinischer Kriterien zur Diagnosestellung. Nervenarzt 65: 653–659PubMedGoogle Scholar
  17. Findley LJ, Koller WC (1987) Essential tremor: a review. Neurology 37: 1194–1197PubMedCrossRefGoogle Scholar
  18. Findley LJ, Gresty MA, Halmagyi GM (1981) Tremor, the cogwheel phenomenon and clonus in Parkinson’s disease. J Neurol Neuro-surg Psychiatry 44: 534–546CrossRefGoogle Scholar
  19. Fischer PA, Baas H, Hefner R (1990) Treatment of parkinsonian tremor with clozapine. J Neural Transm 2: 233–238CrossRefGoogle Scholar
  20. Foster NL, Newman RP, Le Witt PA, Gillespie MM, Larsen TA, Chase TN (1984) Peripheral beta-adrenergic blockade treatment of parkinsonian tremor. Ann Neurol 16: 505–508PubMedCrossRefGoogle Scholar
  21. Fox MW, Ahlskog JE, Kelly PJ (1991) Stereotactic ventrolateralis thalamotomy for medically refractory tremor in post-levodopa era Parkinson’s disease patients [see comments]. J Neurosurg 75: 723–730PubMedCrossRefGoogle Scholar
  22. Friedman JH, Lannon MC (1990) Clozapine-re-sponsive tremor in Parkinson’s disease. Mov Disord 5: 225–229PubMedCrossRefGoogle Scholar
  23. Goldman MS, Ahlskog JE, Kelly PJ (1992) The symptomatic and functional outcome of stereotactic thalamotomy for medically intractable essential tremor. J Neurosurg 76: 924–928PubMedCrossRefGoogle Scholar
  24. Gross R, Amital D (1995) Clozapine in the treatment of tremor in Parkinson’s disease [letter]. Acta Neurol Scand 91/3: 225CrossRefGoogle Scholar
  25. Hassler R, Riechert T, Mundinger F, Umbach W, Gangelberger A (1960) Physiological observations in stereotactic operations in extrapyramidal motor disturbances. Brain 83: 337–350PubMedCrossRefGoogle Scholar
  26. Hirai T, Jones EG (1993) Comparative anatomical study of ventrolateral thalamic mass in humans and monkeys. Stereotact Funct Neurosurg 60: 6–16PubMedCrossRefGoogle Scholar
  27. Huber SJ, Paulson GW (1988) Efficacy of alprazolam for essential tremor. Neurology 38: 241–243PubMedCrossRefGoogle Scholar
  28. Hughes AJ, Daniel SE, Blankson S, Lees AJ (1993) A clinicopathologic study of 100 cases of Parkinson’s disease. Arch Neurol 50: 140–148PubMedCrossRefGoogle Scholar
  29. Jankovic J, Schwartz K (1991) Botulinum toxin treatment of tremors. Neurology 41: 1185–1188PubMedCrossRefGoogle Scholar
  30. Jankovic J, Leder S, Warner D, Schwartz K (1991) Cervical dystonia: clinical findings and associated movement disorders. Neurology 41: 1088–1091PubMedCrossRefGoogle Scholar
  31. Jansen EN (1994) Clozapine in the treatment of tremor in Parkinson’s disease. Acta Neurol Scand 89: 262–265PubMedCrossRefGoogle Scholar
  32. Kelly PJ, Gillingham FJ (1980) The long-term results of stereotaxic surgery and L-dopa therapy in patients with Parkinson’s disease. A 10-year follow-up study. J Neurosurg 53: 332–337PubMedCrossRefGoogle Scholar
  33. Koller WC (1986) Pharmacologic treatment of parkinsonian tremor. Arch Neurol 43:126–127PubMedCrossRefGoogle Scholar
  34. Koller WC, Herbster G (1987) Adjuvant therapy of parkinsonian tremor. Arch Neurol 44: 921–923PubMedCrossRefGoogle Scholar
  35. Koller WC, Vetere OB, Barter R (1989) Tremors in early Parkinson’s disease. J Clin Neurophar-macol 12: 293–297CrossRefGoogle Scholar
  36. Koller WC, Busenbark K, Miner K (1994) The relationship of essential tremor to other movement disorders: report on 678 patients. Essential Tremor Study Group. Ann Neurol 35: 717–723PubMedCrossRefGoogle Scholar
  37. Kornhuber J, Herr B, Thome J, Riederer P (1995) The antiparkinsonian drug budupine binds to NMDA and sigma receptors in postmortem human brain tissue. J Neural Transm [Suppl] 46: 131–137Google Scholar
  38. Krack P, Pollak P, Limousin P, Hoffmann D, Xie J, Benazzouz A, Banabid AL (1988) Subthalamic nucleus or internal pallidal stimulation in young onset Parkinson’s disease. Brain 121: 451–457CrossRefGoogle Scholar
  39. Krack P, Deuschl G, Kaps M, Warnke P, Schneider S, Traupe H (1994) Delayed onset of „rubral tremor“ 23 years after brainstem trauma. Mov Disord 9: 240–242PubMedCrossRefGoogle Scholar
  40. Laihinen A, Rinne UK, Suchy I (1992) Comparison of lisuride and bromocriptine in the treatment of advanced Parkinson’s disease. Acta Neurol Scand 86: 593–595PubMedCrossRefGoogle Scholar
  41. Laitinen LV, Bergenheim AT, Hariz MI (1992) Ventroposterolateral pallidotomy can abolish all parkinsonian symptoms. Stereotact Funct Neurosurg 58: 14–21PubMedCrossRefGoogle Scholar
  42. Lance JW, Schwab RS, Peterson EA (1963) Action tremor and the cogwheel phenomenon in Parkinson’s disease. Brain 86: 95–110PubMedCrossRefGoogle Scholar
  43. Langtry HD, Clissold SP (1990) Pergolide. A review of its pharmacological properties and therapeutic potential in Parkinson’s disease [Review]. Drugs 39: 491–506PubMedCrossRefGoogle Scholar
  44. Loeb C, Priano A (1977) Preliminary evaluation of the effects of clonazepam on parkinsonian tremor. Eur Neurol 15: 143–145PubMedCrossRefGoogle Scholar
  45. Lücking CH, Struppler A, Erbel F (1972) Stereotactic recording from human subthalamic structures. In: Somjen G (ed) Neurophysiology studied in man. Excerpta Medica, Amsterdam, pp 95–99Google Scholar
  46. Marshall J (1968) Tremor. In: Vinken PJ, Bruyn G (eds) Handbook of clinical neurology, vol 8. Elsevier, Amsterdam, pp 809–825Google Scholar
  47. Martin WE, Lowenson RB, Resch JA, Baker AB (1974a) A controlled study comparing trihexyphenidyl hydrochloride plus levodopa with placebo plus levodopa in patients with Parkinson’s disease. Neurology 24: 912–919PubMedCrossRefGoogle Scholar
  48. Martin WE, Lowenson RB, Bilek MK, Resch JA, Baker AB (1974b) Long-term treatment of Parkinson’s disease with levodopa. J Chron Dis 2: 77–93CrossRefGoogle Scholar
  49. Mcdowell F, Lee JE, Swift T, Sweet RD, Ogsbury SS, Kessler JT (1970) Treatment of Parkinson’s disease with levodopa. Ann Intern Med 72: 29–35PubMedGoogle Scholar
  50. Miyamoto T, Bekku H, Moriyama E, Tsuchida S (1985) Present role of stereotactic thalamotomy for parkinsonism. Retrospective analysis of operative results and thalamic lesions in computed tomograms. Appl Neurophysiol 48: 294–304PubMedGoogle Scholar
  51. Mizuno Y, Kondo T, Narabayashi H (1994) Per-golide in the treatment of Parkinson’s disease. Neurology 44: 2006–2014CrossRefGoogle Scholar
  52. Moghal S, Rajput AH, D’arcy C, Rajput R (1994) Prevalence of movement disorders in elderly community residents. Neuroepidemiology 13: 175–178PubMedCrossRefGoogle Scholar
  53. Mundinger F (1985) Postoperative and long-term results of 1561 stereotactic operations in parkinsonism. Appl Neurophysiol 48: 293Google Scholar
  54. Nagaseki Y, Shibazaki T, Hirai T, Kawashima Y, Hirato M, Wada H, Miyazaki M, Ohye C (1985) Long-term follow-up study of selective VIM-thalamotomy [Japanese]. No to Shinkei Brain & Nerve 37: 545–554Google Scholar
  55. Narabayashi H, Maeda T, Yokochi F (1987) Long-term follow-up study of nucleus ventralis in-termedius and ventrolateralis thalamotomy using a microelectrode technique in parkinsonism. Appl Neurophysiol 50: 330–337PubMedGoogle Scholar
  56. Ordenstein L (1867) Sur la Paralysie et la sclerose en plaque generalisee. Martinet, ParisGoogle Scholar
  57. Pahwa R, Koller WC (1995) Dopamine agonists in the treatment of Parkinson’s disease. Cleve Clin J Med 62: 212–217PubMedGoogle Scholar
  58. Pahwa R, Busenbark K, Swanson HE, Dubinsky RM, Hubble JP, Gray C, Koller WC (1995) Botulinum toxin treatment of essential head tremor. Neurology 45: 822–824PubMedCrossRefGoogle Scholar
  59. Pakkenberg H, Pakkenberg B (1986) Clozapine in the treatment of tremor. Acta Neurol Scand 73: 295–297PubMedCrossRefGoogle Scholar
  60. Parkes JD, Baxter JC, Marsden CD, Rees JE (1974) Comparative trial of benzhexol, amantadine and levodopa in the treatment of Parkinson’s disease. J Neurol Neurosurg Psychiatry 37: 422–426PubMedCrossRefGoogle Scholar
  61. Pezzoli G, Martignoni E, Pacchetti C, Angeleri VA, Lamberti P, Muratorio A, Bonuccelli U, De MM, Foschi N, Cossutta E et al. (1994) Per-golide compared with bromocriptine in Parkinson’s disease: a multicenter, crossover, controlled study. Mov Disord 9: 431–436PubMedCrossRefGoogle Scholar
  62. Pezzoli G, Martignoni E, Pacchetti C, Angeleri V, Lamberti P, Muratorio A, Bonuccelli U, De MM, Foschi N, Cossutta E et al. (1995) A crossover, controlled study comparing pergolide with bromocriptine as an adjunct to levodopa for the treatment of Parkinson’s disease. Neurology 45: 186–189CrossRefGoogle Scholar
  63. Piccirilli M, D’Alessandro P, Testa A, Piccinin GL, Agostini L (1985) Bornaprine in the treatment of parkinsonian tremor. Riv Neurol 55: 38–45PubMedGoogle Scholar
  64. Pollak P, Benabid AL, Gervason CL, Hoffmann D, Seigneuret E, Perret J (1993) Long-term effects of chronic stimulation of the ventral intermediate thalamic nucleus in different types of tremor. Adv Neurol 60: 408–413PubMedGoogle Scholar
  65. Rajput AH, Rozdilsky B, Ang L (1991) Occurrence of resting tremor in Parkinson’s disease. Neurology 41: 1298–1299PubMedCrossRefGoogle Scholar
  66. Rajput AH, Pahwa R, Pahwa P, Rajput A (1993) Prognostic significance of the onset mode in parkinsonism. Neurology 43: 829–830PubMedCrossRefGoogle Scholar
  67. Remy P, De Recondo A, Defer G, Loc’h C, Amaren-Co P, Plante BV, Dao C, Bendriem B, Crouzel C, Clanet M (1995) Peduncular „rubral“ tremor and dopaminergic denervation: a PET study. Neurology 45: 472–477PubMedCrossRefGoogle Scholar
  68. Rinne UK (1983) Dopamine agonists in the treatment of Parkinson’s disease. Adv Neurol 37: 141–150PubMedGoogle Scholar
  69. Rinne JO, Lee MS, Thompson PD, Marsden CD (1994) Corticobasal degeneration. A clinical study of 36 cases. Brain 44: 1405–1411Google Scholar
  70. Rix A (1977) Evaluation of an experimental anticholinergic drug, elantrine, in treating the tremor of parkinsonism. Adv Exp Med Biol 90: 277–281PubMedCrossRefGoogle Scholar
  71. Rix A, Fisher RG (1972) Comparison of trihexyphenidyl and dihydromorphanthridine derivative in control of tremor of parkinsonism. South Med J 65: 1385–1389PubMedCrossRefGoogle Scholar
  72. Schneider E, Fischer PA, Clemens R, Balzereit F, Funfgeld EW, Haase HJ (1984) Effects of oral memantine administration on Parkinson symptoms. Results of a placebo-controlled multicenter study [German]. Dtsch Med Wo-chenschr 109: 987–990CrossRefGoogle Scholar
  73. Siegfried J (1993) Therapeutic stereotactic procedures on the thalamus for motor movement disorders. Acta Neurochir 124: 14–18CrossRefGoogle Scholar
  74. Siegfried J, Lippitz B (1982) Chronic electrical stimulation of the VL-VPL complex and of the pallidum in the treatment of movement disorders: personal experience since 1982. Stereo-tact Funct Neurosurg 62: 71–75CrossRefGoogle Scholar
  75. Siegfried J, Lippitz B (1994) Bilateral chronic electrostimulation of ventroposterolateral pallidum: a new therapeutic approach for alleviating all parkinsonian symptoms. Neurosurg 35: 1126–1129CrossRefGoogle Scholar
  76. Spieker S, Löschmann P, Jentgens C, Boose A, Klockgether T, Dichgans J (1995) Tremorlytic activity of budipine: a quantitative study with long-term tremor recordings. Clin Neurophar-macol 18: 266–272CrossRefGoogle Scholar
  77. Strang RR (1965) Orphenadrine in the treatment of Parkinsonism: a two-year study of 150 patients. Med J Aust: 448–450Google Scholar
  78. Struppler A, Lucking CH, Erbel F (1972) Neuro-physiological findings during stereotactic operation in thalamus and subthalamus. Confin Neurol 34: 70–73PubMedCrossRefGoogle Scholar
  79. Tasker RR (1987) Tremor of parkinsonism and stereotactic thalamotomy. Mayo Clin Proc 62: 736–739PubMedCrossRefGoogle Scholar
  80. Tasker RR (1990) Thalamotomy. Neurosurg Clin North Am 1: 841–864Google Scholar
  81. Teychenne PF, Bergsrud D, Racy A, Elton RL, Vern B (1982) Bromocriptine: low-dose therapy in Parkinson disease. Neurology 32: 577–583PubMedCrossRefGoogle Scholar
  82. Thompson PD, Day BL, Rothwell JC, Brown P, Britton TC, Marsden CD (1994) The myoclonus in corticobasal degeneration. Evidence for two forms of cortical reflex myoclonus. Brain 44: 830–837Google Scholar
  83. Trosch RM, Pullman SL (1994) Botulinum toxin A injections for the treatment of hand tremors. Mov Disord 9: 601–609PubMedCrossRefGoogle Scholar
  84. Yahr M, Duvoisin RC (1968) Medical therapy of Parkinsonism. In: Vinken PJ, Bruyn G (eds) Handbook of clinical neurology, vol 8. Elsevier, Amsterdam, pp 283–300Google Scholar
  85. Young RR, Shahani BT (1979) Pharmacology of tremor. Clin Neuropharmacol 4: 139–156CrossRefGoogle Scholar
  86. Zimmermann R, Deuschl G, Hornig A, Schulte-Mönting J, Fuchs G, Lücking CH (1994) Tremors in Parkinson’s disease: symptom analysis and rating. Clin Neuropharmacol 17: 303–314PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Wien 1999

Authors and Affiliations

  • G. Deuschl

There are no affiliations available

Personalised recommendations